Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Virtual Library Resource
(VLR)
last updated: 12 Oct 2014
Bio-resources valuation through selected Literature: A Review
EN
- Government agency (National/Federal)
5th Floor, Ticel Biopark, CSIR Road,
Taramani,
Chennai,
Tamil Nadu600 113, India
Phone: +91 44 2254 2777,
Fax: +91 44 2254 1200,
Email: secretary@nba.nic.in,
Website: http://www.nbaindia.org,
National Biodiversity Authority ,
5th Floor, Ticel Bio Park, CSIR Main Road,
Taramani, Chennai - 600 113.
www.nbaindia.org
EN
2013-01
EN
Original document
EN
National Biodiversity Authority, India
EN
- Biodiversity Valuvation III.pdf [ English ]
This report has been compiled through the UNEP-GEF-MoEF&CC ABS Project. It is an attempt to raise the understanding of economic valuation of biological resources for determination of benefit sharing under the access and benefit sharing mechanism.
EN
- India
- GBF-T13. Fair and equitable sharing of benefits from genetic resources, digital sequence information and associated traditional knowledge
Migrated information
Resource Access: The Secretary, National Biodiversity Authority , 5th Floor, Ticel Bio Park, CSIR Main Road, Taramani, Chennai - 600 113. Phone: +91 44 2254 2777 Fax: +91 44 2254 1200 Emails: secretary@nba.nic.in Websites: http://www.nbaindia.org
Studies on Bio-resources; microorganisms; Genetic Resources; Marine, Coral; Crops; Medicinal Plants; Pharmaceutical Research, valuation,
EN
Resource Access: The Secretary, National Biodiversity Authority , 5th Floor, Ticel Bio Park, CSIR Main Road, Taramani, Chennai - 600 113. Phone: +91 44 2254 2777 Fax: +91 44 2254 1200 Emails: secretary@nba.nic.in Websites: http://www.nbaindia.org
keywords
Studies on Bio-resources; microorganisms; Genetic Resources; Marine, Coral; Crops; Medicinal Plants; Pharmaceutical Research, valuation,
